|
1
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walker C, Baborie A, Crooks D, Wilkins S
and Jenkinson MD: Biology, genetics and imaging of glial cell
tumors. Br J Radio. 84:S90–S106. 2011. View Article : Google Scholar
|
|
4
|
Bailey P and Cushing H: A classification
of the tumours of the glioma group on a histogenetic basis, with a
correlated study of prognosis. Lippincott-Raven; Philadelphia:
1926
|
|
5
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al; European Organisation for Research and Treatment of
Cancer Brain Tumor and Radiotherapy Groups; National Cancer
Institute of Canada Clinical Trials Group. Radiotherapy plus
concomitant and adjuvant temozolomide for glioblastoma. N Engl J
Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sell S: On the stem cell origin of cancer.
Am J Pathol. 176:2584–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma YH, Mentlein R, Knerlich F, Kruse ML,
Mehdorn HM and Held-Feindt J: Expression of stem cell markers in
human astrocytomas of different WHO grades. J Neurooncol. 86:31–45.
2008. View Article : Google Scholar
|
|
8
|
Elsir T, Edqvist PH, Carlson J, Ribom D,
Bergqvist M, Ekman S, Popova SN, Alafuzoff I, Ponten F, Nistér M
and Smits A: A study of embryonic stem cell-related proteins in
human astrocytomas: Identification of Nanog as a predictor of
survival. Int J Cancer. 134:1123–1131. 2014. View Article : Google Scholar
|
|
9
|
Dell'Albani P: Stem cell markers in
gliomas. Neurochem Res. 33:2407–2415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hamerlink P: Cancer stem cells and
glioblastoma. Glioma Cell Biology. Mentlein R and Sedo A:
Springer-Verlag; Wien, New York: pp. 3–23. 2014
|
|
11
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okita K, Ichisaka T and Yamanaka S:
Generation of germline-competent induced pluripotent stem cells.
Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okamoto K, Okazawa H, Okuda A, Sakai M,
Muramatsu M and Hamada H: A novel octamer binding transcription
factor is differentially expressed in mouse embryonic cells. Cell.
60:461–472. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Warren L, Manos PD, Ahfeldt T, Loh YH, Li
H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, et al: Highly
efficient reprogramming to pluripotency and directed
differentiation of human cells with synthetic modified mRNA. Cell
Stem Cell. 7:618–630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gubbay J, Collignon J, Koopman P, Capel B,
Economou A, Münsterberg A, Vivian N, Goodfellow P and Lovell-Badge
R: A gene mapping to the sex-determining region of the mouse Y
chromosome is a member of a novel family of embryonically expressed
genes. Nature. 346:245–250. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zappone MV, Galli R, Catena R, Meani N, De
Biasi S, Mattei E, Tiveron C, Vescovi AL, Lovell-Badge R,
Ottolenghi S, et al: Sox2 regulatory sequences direct expression of
a (beta)-geo transgene to telencephalic neural stem cells and
precursors of the mouse embryo, revealing regionalization of gene
expression in CNS stem cells. Development. 127:2367–2382.
2000.PubMed/NCBI
|
|
17
|
Graham V, Khudyakov J, Ellis P and Pevny
L: SOX2 functions to maintain neural progenitor identity. Neuron.
39:749–765. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Segre JA, Bauer C and Fuchs E: Klf4 is a
transcription factor required for establishing the barrier function
of the skin. Nat Genet. 22:356–360. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gidekel S, Pizov G, Bergman Y and Pikarsky
E: Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer
Cell. 4:361–370. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng S, Maihle NJ and Huang Y:
Pluripotency factors Lin28 and Oct4 identify a sub-population of
stem cell-like cells in ovarian cancer. Oncogene. 29:2153–2159.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Taub R, Kirsch I, Morton C, Lenoir G, Swan
D, Tronick S, Aaronson S and Leder P: Translocation of the c-myc
gene into the immunoglobulin heavy chain locus in human Burkitt
lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA.
79:7837–7841. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hemmati HD, Nakano I, Lazareff JA,
Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Sakariassen PØ, Tsinkalovsky O,
Immervoll H, Bøe SO, Svendsen A, Prestegarden L, Røsland G, Thorsen
F, Stuhr L, et al: CD133 negative glioma cells form tumors in nude
rats and give rise to CD133 positive cells. Int J Cancer.
122:761–768. 2008. View Article : Google Scholar
|
|
27
|
Zhao W, Hisamuddin IM, Nandan MO, Babbin
BA, Lamb NE and Yang VW: Identification of Krüppel-like factor 4 as
a potential tumor suppressor gene in colorectal cancer. Oncogene.
23:395–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jeter CR, Badeaux M, Choy G, Chandra D,
Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ and Tang
DG: Functional evidence that the self-renewal gene NANOG regulates
human tumor development. Stem Cells. 27:993–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wan F, Herold-Mende C, Campos B, Centner
FS, Dictus C, Becker N, Devens F, Mogler C, Felsberg J, Grabe N, et
al: Association of stem cell-related markers and survival in
astrocytic gliomas. Biomarkers. 16:136–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Wang H, Li Z, Wu Q, Lathia JD,
McLendon RE, Hjelmeland AB and Rich JN: c-Myc is required for
maintenance of glioma cancer stem cells. PLoS One. 3:e37692008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Faria MH, Khayat AS, Burbano RR and
Rabenhorst SH: c-MYC amplification and expression in astrocytic
tumors. Acta Neuropathol. 116:87–95. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barker N, Ridgway RA, van Es JH, van de
Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR,
Sansom OJ and Clevers H: Crypt stem cells as the cells-of-origin of
intestinal cancer. Nature. 457:608–611. 2009. View Article : Google Scholar
|
|
34
|
Ignatova TN, Kukekov VG, Laywell ED,
Suslov ON, Vrionis FD and Steindler DA: Human cortical glial tumors
contain neural stem-like cells expressing astroglial and neuronal
markers in vitro. Glia. 39:193–206. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
O'Connor ML, Xiang D, Shigdar S, Macdonald
J, Li Y, Wang T, Pu C, Wang Z, Qiao L and Duan W: Cancer stem
cells: A contentious hypothesis now moving forward. Cancer Lett.
344:180–187. 2014. View Article : Google Scholar
|
|
36
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
38
|
Beier CP and Beier D: CD133 negative
cancer stem cells in glioblastoma. Front Biosci (Elite Ed).
3:701–710. 2011. View
Article : Google Scholar
|
|
39
|
Nishide K, Nakatani Y, Kiyonari H and
Kondo T: Glioblastoma formation from cell population depleted of
Prominin1-expressing cells. PLoS One. 4:e68692009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Varlakhanova NV, Cotterman RF, deVries WN,
Morgan J, Donahue LR, Murray S, Knowles BB and Knoepfler PS: myc
maintains embryonic stem cell pluripotency and self-renewal.
Differentiation. 80:9–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guo Y, Liu S, Wang P, Zhao S, Wang F, Bing
L, Zhang Y, Ling EA, Gao J and Hao A: Expression profile of
embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human
gliomas. Histopathology. 59:763–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Clement V, Sanchez P, de Tribolet N,
Radovanovic I, Ruiz i Altaba A and Altaba R: HEDGEHOG-GLI1
signaling regulates human glioma growth, cancer stem cell
self-renewal, and tumorigenicity. Curr Biol. 17:165–172. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Weina K and Utikal J: SOX2 and cancer:
Current research and its implications in the clinic. Clin Transl
Med. 3:192014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Niu CS, Li DX, Liu YH, Fu XM, Tang SF and
Li J: Expression of NANOG in human gliomas and its relationship
with undifferentiated glioma cells. Oncol Rep. 26:593–601.
2011.PubMed/NCBI
|
|
45
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hattermann K, Held-Feindt J, Lucius R,
Müerköster SS, Penfold ME, Schall TJ and Mentlein R: The chemokine
receptor CXCR7 is highly expressed in human glioma cells and
mediates antiapoptotic effects. Cancer Res. 70:3299–3308. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Holmberg J, He X, Peredo I, Orrego A,
Hesselager G, Ericsson C, Hovatta O, Oba-Shinjo SM, Marie SKN,
Nistér M, et al: Activation of neural and pluripotent stem cell
signatures correlates with increased malignancy in human glioma.
PLoS One. 6:e184542011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ikushima H, Todo T, Ino Y, Takahashi M,
Saito N, Miyazawa K and Miyazono K: Glioma-initiating cells retain
their tumorigenicity through integration of the Sox axis and Oct4
protein. J Biol Chem. 286:41434–41441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ,
Gimotty PA, Guerra M, Guo W and Xu X: Acquired cancer stem cell
phenotypes through Oct4-mediated dedifferentiation. Oncogene.
31:4898–4911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zbinden M, Duquet A, Lorente-Trigos A,
Ngwabyt SN, Borges I, Ruiz i Altaba A and Altaba A: NANOG regulates
glioma stem cells and is essential in vivo acting in a
cross-functional network with GLI1 and p53. EMBO J. 29:2659–2674.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhu XY, Wang L, Luan SH, Zhang HS, Huang
WT and Wang NH: The PGI-KLF4 pathway regulates self-renewal of
glioma stem cells residing in the mesenchymal niches in human
gliomas. Neoplasma. 61:401–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mathieu J, Zhang Z, Zhou W, Wang AJ,
Heddleston JM, Pinna CMA, Hubaud A, Stadler B, Choi M, Bar M, et
al: HIF induces human embryonic stem cell markers in cancer cells.
Cancer Res. 71:4640–4652. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jun HJ, Bronson RT and Charest A:
Inhibition of EGFR induces a c-MET-driven stem cell population in
glioblastoma. Stem Cells. 32:338–348. 2014. View Article : Google Scholar
|
|
54
|
Olmez I, Shen W, McDonald H and Ozpolat B:
Dedifferentiation of patient-derived glioblastoma multiforme cell
lines results in a cancer stem cell-like state with
mitogen-independent growth. J Cell Mol Med. 19:1262–1272. 2015.
View Article : Google Scholar : PubMed/NCBI
|
